MedTrace Logo

Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants

NCT02077088 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2014-03-04

No results posted yet for this study

Summary

Addition of prebiotic galactooligosaccharides to hypoallergenic starter formula would lead to decreased allergic (atopic) symptoms in nonbreastfed infants with a positive history of allergy in family

Conditions

Interventions

OTHER

galactooligosaccharide

addition of food grade GRAS (Generally Regarded As Safe) galactooligosaccharides

Sponsors & Collaborators

  • Vitkovice Hospital

    collaborator OTHER

  • Humana Co.Ltd.

    lead INDUSTRY

Principal Investigators

  • Jan Bozensky, MD · Vitkovice Hospital, Ostrava, Czech Republic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Weeks
Max Age
8 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2012-11-30
Completion
2013-04-30

Countries

  • Czechia

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02077088 on ClinicalTrials.gov